Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Balyasny Asset Management L.P. | WW Ww International, Inc. | 13G | 8.26% | Dec 31, 2023 | 2y |
| AQR CAPITAL MANAGEMENT LLC | AFAR Aura FAT Projects Acquisition Corp Class A Ordinary Shares | 13G/A | 3.44% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | RARE Ultragenyx Pharmaceutical Inc. | 13G/A | 8.4% | Dec 31, 2023 | 2y |
| ORBIMED ADVISORS LLC | APLT Applied Therapeutics, Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | CELC Celcuity Inc. | 13G/A | 5% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | CYT Cyteir Therapeutics, Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| AWM Investment Company, Inc. | ECOR electroCore, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| EcoR1 Capital, LLC | ARVN Arvinas, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Vellar Opportunities Fund Master, Ltd. | ICU SeaStar Medical Holding Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| AQR CAPITAL MANAGEMENT LLC | SBXC SilverBox Corp III | 13G | 5.21% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | XPRO Expro Ltd | 13G/A | 8.5% | Dec 31, 2023 | 2y |
| Teachers Advisors, LLC | ALT Altimmune, Inc. | 13G/A | 2.88% | Dec 31, 2023 | 2y |
| Richard K. Crumly | XPEL XPEL, Inc. | 13G/A | 5.1% | Dec 31, 2023 | 2y |
| Fund 1 Investments, LLC | TTSH Tile Shop Holdings, Inc. | 13G/A | 11.45% | Dec 31, 2023 | 2y |
| CVI Investments, Inc. | EBON Ebang International Holdings Inc. | 13G | 6.8% | Dec 31, 2023 | 2y |
| M3 Funds, LLC | BFIN BankFinancial Corporation | 13G/A | 9.21% | Dec 31, 2023 | 2y |
| Third Rock Ventures IV, L.P. | VYGR Voyager Therapeutics, Inc. | 13G/A | 0.4% | Dec 31, 2023 | 2y |
| TANG CAPITAL MANAGEMENT, LLC | KNTE Kinnate Biopharma Inc. Common Stock | 13G/A | 5.5% | Dec 31, 2023 | 2y |
| Whitefort Capital Management, LP | ABUS Arbutus Biopharma Corp | 13G/A | 7.9% | Dec 31, 2023 | 2y |
| Wynnefield Partners Small Cap Value, L.P. | QRHC Quest Resource Holding Corp | 13G/A | 13.7% | Dec 31, 2023 | 2y |
| Avoro Capital Advisors LLC | XENE Xenon Pharmaceuticals Inc. | 13G/A | 7.7% | Dec 31, 2023 | 2y |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | KCGI Kensington Capital Acquisition Corp. V | 13G | 8.81% | Dec 31, 2023 | 2y |
| Aristotle Capital Management, LLC | CBSH Commerce Bancshares Inc | 13G/A | 6.78% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | IMA ImageneBio, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| Gates Capital Management, Inc. | VSTO Vista Outdoor Inc. | 13G/A | 9.1% | Dec 31, 2023 | 2y |
| Sandia Investment Management LP | PEPL PepperLime Health Acquisition Corporation Class A Ordinary Share | 13G/A | 0% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | HLI Houlihan Lokey, Inc. | 13G/A | 1.6% | Dec 31, 2023 | 2y |
| EdgePoint Investment Group Inc. | MAT Mattel Inc | 13G/A | 13% | Dec 31, 2023 | 2y |
| Omega Fund VI, L.P. | ALPN Alpine Immune Sciences, Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| SAMLYN CAPITAL, LLC | INZY Inozyme Pharma, Inc. Common Stock | 13G | 5.5% | Dec 31, 2023 | 2y |
| Dragoneer Investment Group, LLC | JAMF Jamf Holding Corp. Common Stock | 13G/A | 13.1% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | TGVC TG Venture Acquisition Corp. Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Par Sanda | BHM Bluerock Homes Trust, Inc. | 13G/A | 13.04% | Dec 31, 2023 | 2y |
| Chi Fung Cheng | CRDO Credo Technology Group Holding Ltd | 13G/A | 6.5% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | AIRG Airgain Inc | 13G/A | 5.92% | Dec 31, 2023 | 2y |
| William R. Kruse | REI Ring Energy, Inc. | 13G/A | 7% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | ETNB 89bio, Inc. Common Stock | 13G/A | 7.8% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | RLAY Relay Therapeutics, Inc. | 13G | 7% | Dec 31, 2023 | 2y |
| Granahan Investment Management, LLC | GENI Genius Sports Ltd | 13G | 6.27% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | IVCB Investcorp Europe Acquisition Corp I Class A Ordinary Shares | 13G/A | 9.93% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | ISEE IVERIC bio, Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| D. E. Shaw & Co., L.P. | PEGR Project Energy Reimagined Acquisition Corp. Class A Ordinary Share | 13G/A | 1.1% | Dec 31, 2023 | 2y |
| Paradigm Biocapital Advisors LP | NUVL Nuvalent, Inc. | 13G/A | 6.7% | Dec 31, 2023 | 2y |
| CADIAN CAPITAL MANAGEMENT, LP | BRZE Braze, Inc. | 13G/A | 2.3% | Dec 31, 2023 | 2y |
| OLP CAPITAL MANAGEMENT Ltd | QFIN Qfin Holdings, Inc. | 13G | 8% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | DPCS DP Cap Acquisition Corp I Class A Ordinary Shares | 13G | 9.06% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | JSPR Jasper Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Oaktree Opps Xb Holdco Ltd. | EXE EXPAND ENERGY Corp | 13G/A | 5.34% | Dec 31, 2023 | 2y |
| MOORE CAPITAL MANAGEMENT, LP | SUAC ShoulderUp Technology Acquisition Corp. | 13G | 6% | Dec 31, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | FOLD AMICUS THERAPEUTICS, INC. | 13G/A | 9.6% | Dec 31, 2023 | 2y |